# EDGAR Filing Document

**Accession Number:** 0001670747
**File Stem:** 0001641172-25-017138
**Filing Date:** 2025-6
**Character Count:** 2011
**Document Hash:** 8e8f32036b0f72d44540fa11a0503226
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001641172-25-017138.hdr.sgml**: 20250630

**ACCESSION NUMBER**: 0001641172-25-017138

**CONFORMED SUBMISSION TYPE**: 1-Z

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250630

**DATE AS OF CHANGE**: 20250630

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BirchBioMed Inc.
- **CENTRAL INDEX KEY:** 0001670747
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** A1
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 1-Z
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 24R-00980
- **FILM NUMBER:** 251092186

**BUSINESS ADDRESS:**
- **STREET 1:** 130 KINGSCROSS DRIVE
- **CITY:** KING CITY
- **STATE:** A6
- **ZIP:** L7B 1E6
- **BUSINESS PHONE:** 866-350-1993

**MAIL ADDRESS:**
- **STREET 1:** 130 KINGSCROSS DRIVE
- **CITY:** KING CITY
- **STATE:** A6
- **ZIP:** L7B 1E6

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 1-Z

### EXIT REPORT UNDER REGULATION A

### Filer Information

**Issuer CIK:** 0001670747

**Issuer CCC:** XXXXXXXX

**Is this a LIVE or TEST Filing?:** LIVE

### Item 1: Issuer Information

**Name of Issuer:** BirchBioMed Inc.

**Address:** 130 Kingscross Drive, King City, A6 L7B 1E6

**Telephone Number:** 905-833-3414

**Commission File Number:** 024-12475

### Part II: Certification of Suspension of Duty to File Reports

**Title of each class of securities:** Common Shares, no par value

**File Number for the Regulation A offering statement:** 024-12475

**Approximate number of holders of record as of the certification date:** 120

### Signature

Pursuant to the requirements of Regulation A, the issuer has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

**CIK:** 0001670747

**Issuer:** BirchBioMed Inc.

**By (Signature):** /s/ Mark S. Miller

**Title:** Chief Executive Officer

**Date:** 06-30-2025